This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Apr;14(2):42-3.

doi: 10.1136/ebm.14.2.42.

Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD

Matthew B Stanbrook¹

Affiliations

PMID: 19332598
DOI: 10.1136/ebm.14.2.42

Comment

Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD

Matthew B Stanbrook. Evid Based Med. 2009 Apr.

. 2009 Apr;14(2):42-3.

doi: 10.1136/ebm.14.2.42.

Author

Matthew B Stanbrook¹

Affiliation

¹ University Health Network, University of Toronto, Toronto, Ontario, Canada.

PMID: 19332598
DOI: 10.1136/ebm.14.2.42

No abstract available

PubMed Disclaimer

Comment on

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Singh S, Loke YK, Furberg CD. Singh S, et al. JAMA. 2008 Sep 24;300(12):1439-50. doi: 10.1001/jama.300.12.1439. JAMA. 2008. PMID: 18812535

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.